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Abstract
Regular physical activity (PA) is associated with reduced risk of the development and progression of musculoskeletal, meta-
bolic and vascular disease. However, PA declines with age and this can contribute to multiple adverse outcomes. The aims 
of this study were to describe the relationship between accelerometer-determined PA, body composition and sarcopenia (the 
loss of muscle mass and function with age). Seven-day PA was measured using the GENEactiv accelerometer among 32 men 
and 99 women aged 74–84 years who participated in the Hertfordshire Sarcopenia Study. We measured mean daily accelera-
tion and minutes/day spent in non-sedentary and moderate-to-vigorous physical activity (MVPA) levels. Body composition 
was measured by dual-energy X-ray absorptiometry, muscle strength by grip dynamometry and function by gait speed. 
Sarcopenia was defined according to the EWGSOP diagnostic algorithm. Men and women spent a median (inter-quartile 
range) of 138.8 (82, 217) and 186 (122, 240) minutes/day engaging in non-sedentary activity but only 14.3 (1.8, 30.2) and 
9.5 (2.1, 18.6) min in MVPA, respectively. Higher levels of PA were associated with reduced adiposity, faster walking speed 
and decreased risk of sarcopenia. For example, a standard deviation (SD) increase in mean daily acceleration was associated 
with an increase in walking speed of 0.25 (95% CI 0.05, 0.45) SDs and a reduction in the risk of sarcopenia of 35% (95% CI 
1, 57%) in fully adjusted analyses. PA was not associated with hand grip strength. Community-dwelling older adults in this 
study were largely sedentary but there was evidence that higher levels of activity were associated with reduced adiposity and 
improved function. PA at all intensity levels in later life may help maintain physical function and protect against sarcopenia.
Keywords Objectively measured physical activity · Accelerometer · Body composition · Physical performance · Sarcopenia
Introduction
Sarcopenia is associated with a broad array of adverse physi-
cal, metabolic and health-related changes such as reduced 
mobility, falls, fractures, diabetes, poorer health-related 
quality of life and death [1, 2]. Physical activity (PA) is 
defined as bodily movement produced by the bone/muscle 
unit that results in energy expenditure [3]. Engagement in 
regular PA such as walking, cycling, work-related activity, 
sports, gym work, dancing or gardening has been associated 
with a reduction in the risk of development, or progression, 
of cardiovascular and cerebrovascular disease, type II dia-
betes, cognitive decline, obesity, falls and fractures [4–6]. 
Other benefits of regular physical activity include a greater 
sense of well-being and self-esteem [7].
However, physical inactivity and sedentary behaviour are 
common among older people which can lead to an accelera-
tion in muscle catabolism as well as reduced aerobic capac-
ity. In conjunction with other personal, social and environ-
mental factors (such as access to food and social isolation), 
a decline in physical activity can create a spiral of further 
inactivity, muscle loss, weight gain, mobility disability and 
an increase in cardio-metabolic risk [8, 9]. Therefore, meas-
urement and monitoring of PA and improved understanding 
of its associations with health outcomes are important to 
inform public health policy.
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Objective measurement of physical activity with acceler-
ometers has gained acceptance as a preferred method for the 
collection of data on the duration, frequency and intensity 
of activity [10] and is acceptable for large scale epidemio-
logical studies in older people [4, 11]. Several studies have 
explored the associations between objectively measured PA 
and measures of body composition and function [12–16]. 
For example, higher physical activity and low sedentary 
activity were associated with lower body mass index (BMI) 
in a cross-sectional analysis of the LIFE study [12]. Aggio 
et al. showed that in a cohort of 1286 older men aged 70–92, 
higher levels of MVPA were associated with reduced risk 
of sarcopenia as defined by the European Working Group 
on Sarcopenia in Older People (EWGSOP) but where low 
muscle mass was defined by lower mid-upper arm circum-
ference (MUAC) [4]. In a study of 636 community-dwelling 
older men and women 59–73 years, Foong et al. showed that 
higher intensities of PA were associated with higher lean 
mass and stronger lower limb strength [11]. Associations 
between PA and better function have also been observed in 
older adults in assisted care facilities. For example, better 
accelerometer-based PA was associated with a better short 
physical performance battery (SPPB) score, grip strength 
and faster walk speed in older adults aged over 65 [17]. A 
recent meta-analysis of 25 studies by Steffl et al. concluded 
that PA, measured by self-report as well as with accelerom-
eters, was associated with reduced odds of acquiring lower 
muscle mass or ‘sarcopenia’, in later life [18].
Therefore, our aim for this study was to explore the cross-
sectional associations between accelerometer derived PA 
in relation to body composition and sarcopenia as defined 
by the EWGSOP. This study benefits from the availabil-
ity of both objectively measured PA and comprehensive 
characterisation of muscle mass and function by DXA, 
grip dynamometry and physical performance measures in 
healthy community-dwelling older men and women aged 
74–84 years.
Methods
Participants
The Hertfordshire Sarcopenia Study (HSS) is a retro-
spective cohort study designed to investigate life course 
influences on muscle morphology, mass and strength in 
community-dwelling older people. The first phase of the 
study focusing on men has previously been described in 
detail [19]. The second phase of the study (2012–2015) 
recruited both men and women, herein termed HSSe. 
Briefly, 1188 participants from the UK Hertfordshire 
Cohort Study (HCS) [20] were identified as the target 
sample for HSSe. Of these, 303 wished to participate in 
the study. All participants were contacted by telephone 
consecutively and the following clinical exclusion criteria 
were applied: concurrent use of anticoagulant medication, 
neuromuscular comorbidity or diabetes. One hundred and 
ninety-nine participants (66%) were eligible, available and 
were willing to have a home visit by the research team. 
Of these, 18 participants were excluded at the time of the 
home visit due to concurrent medical conditions requiring 
follow-up and 12 declined to participate further. A total 
of 169 participants were scheduled to attend a research 
clinic, but one further participant was excluded at the time 
of clinical review. Overall, 44 men and 124 women had 
detailed assessments of body composition and muscle 
function (Fig. 1).
Fig. 1  Flow diagram for the analysis sample
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Recording of Accelerometry Data
At the time of the home visit, participants were asked to 
wear a GENEActiv (ActivInsights Ltd, Cambridgeshire, 
UK) accelerometer on the non-dominant wrist to objectively 
measure their physical activity. Given limited supply of the 
accelerometers, devices were activated and posted to par-
ticipants in some instances. Recordings were made over a 
7-day period after the participant started wearing the device. 
All devices were returned from participants by post. There-
after, GENEActiv data were downloaded using GENEActiv 
PC software version 2.2 and saved in raw format as binary 
files. Accelerometer data were processed in R (http://www.
cran.r-proje ct.org) using R-package GGIR [21]. Recording 
frequencies of 100 and 25 Hz were used.
Derivation of Objective Physical Activity Measures
A detailed account of the processing of accelerometer data 
is presented in the supplementary pages online. For each 
participant, mean daily (over 24-h period) physical activ-
ity measures included overall acceleration in milli-g (mg), 
daily time spent in MVPA (≥ 100 mg) and daily time spent 
in non-sedentary physical activity levels (≥ 40 mg). The 
cut-off value for MVPA corresponds to approximately three 
metabolic equivalents (METs) for adults and has been used 
in other studies of community-dwelling older people [22, 
23]. The range 0–40 mg was chosen as the sedentary cat-
egory in a previous study involving the use of the GENE-
Activ accelerometer in older people (average age 79 years) 
[24]. Overall, 30 participants (18%) were excluded from the 
analysis for the following reasons: unable to contact; refusal 
to wear the device; technical problem with the accelerometer 
or excessive periods of non-wear detected in preliminary 
analysis. A total of 138 recordings were processed. Of these, 
two participants had recordings of less than 7 days; one had 
taken the device off to sleep; and four had unfeasible values 
and were excluded from analyses. Consequently, the analy-
sis sample comprised 131 participants (32 men, 99 women) 
with objective physical activity recordings. A flow diagram 
for the analysis sample is provided in Fig. 1. There were no 
statistically significant differences regarding the outcome 
variables of interest between participants with and without 
suitable physical activity data.
Measurement of Anthropometry, Physical 
Performance and Body Composition
Height in centimetres (cm) and weight in kilograms (kg) 
were measured once. Body composition [total lean mass, 
appendicular lean mass (ALM), and fat mass] was assessed 
by dual-energy X-ray absorptiometry (DXA) (Hologic Dis-
covery, software version 12.5) for all participants. Isometric 
grip strength (kg) was measured three times in each hand 
using a Jamar handheld hydraulic dynamometer (Promed-
ics, UK) and the maximum value of six measures was used 
for analysis. Customary walking speed was measured over a 
three-metre course. Both the DXA machine and dynamom-
eter were calibrated before the study and at regular intervals 
throughout the study.
Derivation of Sarcopenia Status
Sarcopenia status at follow-up was derived using the EWG-
SOP diagnostic algorithm with the following cut-points: 
appendicular lean mass index (ALM/height2) ≤ 7.23 kg/m2 
for men (≤ 5.67 kg/m2 for women); grip strength < 30 kg for 
men (< 20 kg for women); and walking speed ≤ 0.8 m/s [25]. 
Participants with slow walking speed or weak grip strength, 
and who also had low ALM index were classed as having 
sarcopenia.
Ascertainment of Socio‑demographic and Lifestyle 
Factors
Social history was ascertained during the HCS baseline 
interview. At the HSSe interview, smoking status and weekly 
alcohol consumption were ascertained and details of all pre-
scription and over-the-counter medications currently taken 
were coded according to the British National Formulary. 
Medication use across body wide systems (termed number 
of systems medicated) was used as a marker of comorbid-
ity. We did not ascertain whether our participants were 
engaged in resistance or endurance-based activity in their 
leisure time.
Statistical Methods
Height and weight were highly correlated (r = 0.46, p < 0.009 
for men; r = 0.43, p < 0.001 for women). To account for 
multi-collinearity, a sex-specific standardised residual of 
weight-adjusted-for-height was derived for inclusion with 
height in regression models. Registrar General’s social class 
was coded from the 1990 Standard Occupational Classifi-
cation (SOC90) unit group for occupation using computer-
assisted standard occupational coding [26]. Current social 
class was coded from current or most recent full-time occu-
pation for men and women who never married, and from 
husband’s occupation for ever-married women.
Data were described using summary statistics. Mean 
daily time spent in MVPA was skewed and included zeros 
and was therefore square-root transformed; the other 
physical activity measures and continuous outcome vari-
ables were normally distributed. Associations between 
physical activity measures were examined using Pearson 
correlations. Linear regression was used to examine the 
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associations between each mean daily physical activity 
measure (acceleration, time in non-sedentary levels and 
time in MVPA levels) and the following outcomes: weight, 
BMI, total fat mass, ALM index, grip strength and walking 
speed. Poisson regression models with a robust variance 
estimator to yield relative risks were used for sarcopenia as 
the outcome variable. Gender-adjusted and fully adjusted 
models (accounting for gender, age, height, weight-for-
height residual, smoking, alcohol and social class) were 
implemented. Gender-adjusted and fully adjusted models 
for ALM index and sarcopenia were adjusted for total 
fat mass and not for height or weight-for-height resid-
ual. Models for weight, BMI and total fat mass were not 
adjusted for any adiposity measures and models for BMI 
were also not adjusted for height. Sex-specific standard 
deviation (SD) scores were coded for physical activity 
measures and continuous outcomes in models. Due to 
the small number of men in the sample (n = 32), pooled 
gender-adjusted analyses were conducted. All data were 
analysed using Stata, release 14.2 (STATA Corp, College 
Station, TX, USA).
Results
Participant Characteristics
The average age at the time of wearing the accelerometer 
was 79 years. Median daily time spent at non-sedentary 
activity levels was 138 and 186  min among men and 
women, respectively. In contrast, the median daily time 
spent in MVPA was only 14.3 min for men and 9.5 min 
for women. Overall 5 (16.1%) men and 21 (21.6%) women 
had sarcopenia (Table 1).
Table 1  Participant 
characteristics
Maximum number of missing observations was nine (total body fat, fat mass index and walking speed)
Manual social class: categories IIIM-V from 1990 OPCS Standard Occupational Classification
Three individuals could not walk without another person’s help and four used a walking aid so their values 
of walking speed were set to missing
M men, W women, MVPA moderate-to-vigorous physical activity
+ Average daily (24 h) acceleration for each participant
a n (%)
b Median (lower quartile, upper quartile)
Mean (SD) Men (n = 32) Women (n = 99)
Age (years) 78.6 (2.7) 78.9 (2.3)
Height (cm) 172.4 (6.1) 159.4 (5.9)
Weight (kg) 78.9 (12.2) 70.8 (12.3)
BMI (kg/m2) 26.5 (3.7) 27.8 (4.4)
Total body fat mass (kg) 27.1 (9) 31.1 (8.3)
Fat mass index (kg/m2) 9.1 (3.0) 12.2 (3.2)
Appendicular lean mass (kg) 21.3 (2.8) 15.2 (2.4)
Appendicular lean mass index (kg/m2) 7.2 (0.9) 6.0 (0.8)
Grip strength (kg) 34.8 (6.5) 20.7 (5.6)
Walking speed (m/s) 0.98 (0.18) 0.96 (0.19)
EWGSOP  sarcopeniaa 5 (16.1%) 21 (21.6%)
Ever  smokeda 14 (43.8%) 38 (38.4%)
Social class (manual)a 13 (43.3%) 49 (49.5%)
Ever  smokedb 14 (43.8%) 38 (38.4%)
Alcohol consumption (units per week)a
 Very low (< 1) 7 (21.9%) 55 (55.6%)
 Low (1–10 M, 1–7 W) 16 (50%) 32 (32.3%)
 Moderate (11–21 M, 8–14 W) 5 (15.6%) 10 (10.1%)
 High (> 21 M, > 14 W) 4 (12.5%) 2 (2%)
Acceleration (mg)+ 23.9 (7.6) 25.5 (6.8)
Non-sedentary (min/day)b 137.8 (81.7, 217.2) 186.0 (122.1, 240.4)
MVPA (min/day)b 14.3 (1.8, 30.2) 9.5 (2.1, 18.6)
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Associations Between Objective Measures 
of Physical Activity and Body Composition 
and Sarcopenia
Mean daily acceleration was strongly correlated with non-
sedentary time (r = 0.92). Time spent in MVPA was cor-
related with daily acceleration (r = 0.73) and non-sedentary 
time (r = 0.65) (p < 0.05 for all correlations). Relationships 
between physical activity measures and ALM index, grip 
strength and walking speed are presented in Table 2 as well 
as Fig. 2. Greater non-sedentary time was weakly associated 
(p = 0.07) with higher ALM index after adjustment for gen-
der and total fat mass but this was attenuated by full adjust-
ment. Greater level of daily acceleration and increased non-
sedentary time were associated with faster walking speed in 
gender-adjusted and fully adjusted analyses. For example, a 
one SD increase in non-sedentary time was associated with 
an average increase in walking speed of 0.27 (95% CI 0.08, 
0.46) SDs in fully adjusted analyses. None of the physical 
activity measures were associated with grip strength. Higher 
physical activity according to each of the three measures was 
associated with reduced risk of sarcopenia after adjustment 
Table 2  SD difference in ALM 
index, grip strength, walking 
speed and relative risks for 
sarcopenia per SD increase in 
the physical activity measures
For each participant, mean daily physical activity measures were derived
SD standard deviation, ALM appendicular lean mass
Gender- and fully adjusted models for ALM index and sarcopenia were adjusted for total fat mass and not 
for height or weight-for-height residual
Estimates for sarcopenia are relative risks obtained from Poisson regression models with a robust variance 
estimator. All other estimates are regression coefficients obtained from linear regression models
a Adjusted for gender, age, height, weight-for-height residual, smoking history (ever vs. never), alcohol con-
sumption, and social class (manual vs. non-manual)
Physical activity measure Outcome Adjusted for gender Fully  adjusteda
Estimate (95% CI) p value Estimate (95% CI) p value
Acceleration ALM index 0.15 (− 0.03, 0.32) 0.10 0.12 (− 0.07, 0.30) 0.21
Grip strength 0.11 (− 0.07, 0.28) 0.24 0.12 (− 0.08, 0.31) 0.23
Walking speed 0.26 (0.08, 0.44) 0.01 0.25 (0.05, 0.45) 0.02
Sarcopenia 0.67 (0.47, 0.95) 0.03 0.65 (0.43, 0.99) 0.05
Time in non-sedentary levels ALM index 0.16 (− 0.01, 0.33) 0.07 0.14 (− 0.04, 0.31) 0.13
Grip strength 0.15 (− 0.02, 0.33) 0.08 0.16 (− 0.03, 0.34) 0.09
Walking speed 0.29 (0.12, 0.47) < 0.001 0.27 (0.08, 0.46) 0.01
Sarcopenia 0.66 (0.45, 0.96) 0.03 0.67 (0.44, 1.01) 0.06
Time in MVPA levels ALM index 0.06 (− 0.12, 0.24) 0.51 0.01 (− 0.18, 0.20) 0.93
Grip strength 0.10 (− 0.08, 0.27) 0.29 0.11 (− 0.09, 0.31) 0.27
Walking speed 0.19 (0.01, 0.37) 0.04 0.16 (− 0.05, 0.37) 0.14
Sarcopenia 0.65 (0.43, 0.98) 0.04 0.70 (0.43, 1.13) 0.14
Fig. 2  SD difference in outcomes (95% CI) per SD increase in physi-
cal activity measures (fully adjusted associations). Estimates are 
adjusted for gender, age, height, weight-for-height residual, smoking 
history (ever vs. never), alcohol consumption, and social class (man-
ual vs. non-manual). ALM index was adjusted for total fat mass and 
not for height or weight-for-height residual. SD standard deviation, 
ALM appendicular lean mass, Mean acc mean acceleration, Non-sed 
non-sedentary, MVPA moderate-to-vigorous physical activity. For 
each participant, mean daily physical activity measures were derived. 
*p < 0.05
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for gender and total fat mass (p < 0.05); associations regard-
ing mean daily acceleration were robust in fully adjusted 
analyses (p = 0.047). Associations were not substantially 
altered when additionally adjusted for the number of systems 
medicated (data not shown).
Associations Between Physical Activity Measures 
and Weight, BMI and Fat Mass
Associations between physical activity measures and weight, 
BMI and fat mass are presented in Table 3. In gender-
adjusted and fully adjusted analyses, higher physical activ-
ity was associated with lower weight, BMI, and fat mass, 
regardless of the physical activity measure used.
Discussion
In this study of community-dwelling older men and women, 
we have shown that a higher level of objectively measured 
PA was associated with reduced adiposity, increased func-
tion (faster walking speed) and decreased risk of sarcopenia. 
PA was not significantly associated with muscle strength or 
ALM index.
Older men and women in this study only spent a median 
of 14 and 10 min a day engaging in moderate-to-vigorous 
physical activity, respectively, falling significantly short of 
the WHO’s recommendation of at least 150 min of mod-
erate-intensity aerobic physical activity throughout the 
week for a sustained health benefit [27]. Our results are in 
accordance with other studies which have shown that older 
adults engage in significantly fewer minutes of MVPA not 
only when compared with young adults, but also relative 
to recommended guidelines [28]. Previous studies of older 
people have also utilised the threshold of 100 mg to identify 
MVPA (≥ 3 METS) [22, 23]; however, it should be acknowl-
edged that this threshold was not explicitly developed for 
older adults [29]. This may explain the low levels of MVPA 
that were apparent in our study. Importantly however, 
greater time spent at any non-sedentary level of PA may 
confer health benefits [30, 31]. For example, a recent system-
atic review and meta-analysis by Hupin et al. reported that 
MVPA in adults, even below current recommended levels, 
conferred a lower mortality risk [32].
Our results regarding associations between PA and adi-
posity are consistent with the literature. Time spent in non-
sedentary activity as well as MVPA has been shown to be 
associated with lower adiposity and lower BMI in several 
population-based studies [4, 33, 34] and a systematic review 
by Fuzeki et al. concluded that engagement in light PA was 
associated with less risk of developing obesity [35].
Our results regarding the positive associations (p < 0.07) 
observed between PA and ALM index are also in broad 
agreement with those reported in the literature. For exam-
ple, Foong et al. showed that among community-dwelling 
older men and women, light as well as higher intensity lev-
els of PA were positively associated with higher lean mass 
percentage whilst sedentary activity had the opposite effect 
[11]. In studies of older Japanese men, moderate or vigorous 
physical activity (≥ 3 metabolic equivalents [METS]) was 
associated with lower lean mass index [36], a finding not 
replicated in our study (although the majority of our sample 
were female).
We did not see an association between PA and grip 
strength in our study. Although Gerdhem et al. found no 
association between accelerometer-based PA and knee 
Table 3  SD difference in weight, BMI and fat mass per SD increase in the physical activity measures
For each participant, mean daily physical activity measures were derived
Models for BMI were not adjusted for height
Estimates are regression coefficients obtained from linear regression models
SD standard deviation
a Adjusted for gender, age, height, smoking history (ever vs. never), alcohol consumption, and social class (manual vs. non-manual)
Physical activity measure Outcome Gender-adjusted Fully  adjusteda
Estimate (95% CI) p value Estimate (95% CI) p value
Acceleration Weight − 0.43 (− 0.58, − 0.27) < 0.001 − 0.40 (− 0.55, − 0.26) < 0.001
BMI − 0.46 (− 0.61, − 0.30) < 0.001 − 0.45 (− 0.61, − 0.30) < 0.001
Fat mass − 0.50 (− 0.66, − 0.34) < 0.001 − 0.49 (− 0.64, − 0.33) < 0.001
Time in non-sedentary levels Weight − 0.35 (− 0.51, − 0.19) < 0.001 − 0.33 (− 0.48, − 0.18) < 0.001
BMI − 0.39 (− 0.55, − 0.23) < 0.001 − 0.37 (− 0.54, − 0.21) < 0.001
Fat mass − 0.46 (− 0.62, − 0.30) < 0.001 − 0.44 (− 0.59, − 0.28) < 0.001
Time in MVPA levels Weight − 0.43 (− 0.58, − 0.27) < 0.001 − 0.41 (− 0.56, − 0.26) < 0.001
BMI − 0.42 (− 0.58, − 0.26) < 0.001 − 0.45 (− 0.61, − 0.29) < 0.001
Fat mass − 0.49 (− 0.64, − 0.33) < 0.001 − 0.51 (− 0.67, − 0.35) < 0.001
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muscle strength [37], the large cross-sectional study of older 
men by Aggio et al. identified positive associations between 
PA and both grip strength and physical performance [4]. 
In addition, a large population-based cross-sectional study 
identified associations between light, moderate and vigorous 
accelerometer-based physical activity and stronger leg and 
knee extension strength [11]. Furthermore, sedentary behav-
iour ascertained by questionnaire analysis was associated 
with lower grip strength in a study by Hamer and Stamatakis 
[38]. Other studies have also reported positive associations 
between objective measures of PA and grip strength [12, 
17]. It is possible that HSSe participants may not have been 
taking part in activities that benefit upper extremity strength. 
This may provide an explanation for our results [39].
Our finding that increased non-sedentary time was associ-
ated with faster gait speed is consistent with previous stud-
ies that have reported associations between higher levels of 
objectively measured light or moderate-to-vigorous PA and 
better physical performance [40, 41]. Our results suggest an 
association between higher levels of PA and a lower risk of 
sarcopenia. In support of our findings, associations between 
PA and a lower risk of acquiring sarcopenia were confirmed 
in a recent meta-analysis [18]. To our knowledge, only one 
previous study has reported an association between higher 
MVPA and reduced risk of developing severe sarcopenia 
according to the EWGSOP diagnostic algorithm [4].
Our study has some limitations. First, a healthy responder 
bias has been observed in HCS and is also evident in HSSe. 
However, as our analyses were internal, unless there was a 
systematic difference in the observations of interest among 
our study participants and those who were invited to take 
part in the study but did not, no major bias should have 
occurred. Second, we have a relatively small sample size 
with no ethnic diversity but this was the largest available; 
higher attrition from the target sample was expected due 
to the commitment required from participants to wear the 
device for 7 days. Third, a cross-sectional study design 
precludes any judgment regarding causality. Fourth, par-
ticipants wore the accelerometer during different months of 
the year which may have influenced their physical activity 
levels.
Our study also has many strengths. First, the HSSe has a 
comprehensive set of muscle outcomes (muscle mass and body 
composition, strength and function) making this relatively 
unusual among other studies. The study was conducted accord-
ing to strict protocols by an experienced multi-disciplinary 
research team. Second, we have obtained objective measures 
of PA. The GENEActiv and other wearable accelerometers 
accurately discriminate between different PA intensities and 
are acceptable and feasible to use in cohorts of older people 
as they are non-intrusive, waterproof, robust and importantly 
store substantial amounts of data [42]. In addition, the high cri-
terion validity of this device in relation to energy expenditure 
(left wrist, r = 0.86; right wrist, r = 0.83) and high reliability 
(intra-individual variance 1.4%, inter-individual variance 
2.1%) have been reported previously [43]. A minimum of 6 
days including weekends is recommended to capture habitual 
PA which was within the scope of our fieldwork. Finally, we 
implemented a robust methodology for data extraction and 
summary of the data recorded by the GENEactiv device. Ref-
erence details [44–49] are given in supplementary material.
In conclusion, we have shown that higher levels of objec-
tively measured PA are associated with reduced adiposity, 
increased muscle mass, function and decreased risk of sar-
copenia. Our results contribute to better understanding of the 
consequences of different levels of PA and sedentary behav-
iour among older people. These results suggest that incre-
mental elevations in habitual physical activity in older people 
may help to decelerate age-related declines in musculoskeletal 
fitness.
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